132 related articles for article (PubMed ID: 2791491)
1. Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
Neu HC; Saha G; Chin NX
Diagn Microbiol Infect Dis; 1989; 12(3):283-5. PubMed ID: 2791491
[TBL] [Abstract][Full Text] [Related]
2. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods.
Pankuch GA; Jacobs MR; Rittenhouse SF; Appelbaum PC
Antimicrob Agents Chemother; 1994 Oct; 38(10):2317-22. PubMed ID: 7840563
[TBL] [Abstract][Full Text] [Related]
3. Susceptibilities of 97 strains of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
Ismaeel NA
Microbios; 1997; 91(367):97-103. PubMed ID: 9467924
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of 100 strains of Stenotrophomonas maltophilia to three beta-lactams and five beta-lactam-beta-lactamase inhibitor combinations.
Lecso-Bornet M; Bergogne-Bérézin E
J Antimicrob Chemother; 1997 Nov; 40(5):717-20. PubMed ID: 9421322
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847
[TBL] [Abstract][Full Text] [Related]
7. Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Dec; 38(12):2905-7. PubMed ID: 7695281
[TBL] [Abstract][Full Text] [Related]
8. Double-disk synergy test positivity in Stenotrophomonas maltophilia clinical strains.
Hejnar P; Kolár M; Chmela Z
Folia Microbiol (Praha); 2004; 49(1):71-4. PubMed ID: 15114869
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.
Muñoz Bellido JL; Muñoz Criado S; García García I; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
Antimicrob Agents Chemother; 1997 Dec; 41(12):2612-5. PubMed ID: 9420028
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T
Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
[TBL] [Abstract][Full Text] [Related]
11. Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.
Visalli MA; Jacobs MR; Moore TD; Renzi FA; Appelbaum PC
Antimicrob Agents Chemother; 1997 Apr; 41(4):767-70. PubMed ID: 9087486
[TBL] [Abstract][Full Text] [Related]
12. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.
Vartivarian S; Anaissie E; Bodey G; Sprigg H; Rolston K
Antimicrob Agents Chemother; 1994 Mar; 38(3):624-7. PubMed ID: 8203865
[TBL] [Abstract][Full Text] [Related]
13. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
Wang H; Chen MJ;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activities of seven new beta-lactams, alone and in combination with beta-lactamase inhibitors, against clinical isolates resistant to third generation cephalosporins.
Gupta V; Datta P; Agnihotri N; Chander J
Braz J Infect Dis; 2006 Feb; 10(1):22-5. PubMed ID: 16767311
[TBL] [Abstract][Full Text] [Related]
15. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.
Jacoby GA; Carreras I
Antimicrob Agents Chemother; 1990 May; 34(5):858-62. PubMed ID: 2193623
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
[TBL] [Abstract][Full Text] [Related]
17. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
Medeiros AA; Hare R; Papa E; Adam C; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.
Hornstein MJ; Jupeau AM; Scavizzi MR; Philippon AM; Grimont PA
Antimicrob Agents Chemother; 1985 May; 27(5):806-11. PubMed ID: 2990327
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
